BOARD OF DIRECTORS
ACUTE SUICIDAL CRISIS
IN BIPOLAR DEPRESSION
MECHANISM OF ACTION
IN THE NEWS
Neurorx, inc. is a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders
Recent scientific breakthroughs suggest the chemical target for suicidality in bipolar depression may be localized in the brain’s NMDA receptor
The first oral therapeutic being developed for the treatment of acute suicidal crisis in bipolar disorder
View the latest press releases and media coverage for Neurorx
© 2016 NeuroRx, Inc.
*This drug is investigational and not yet approved by the U.S. The compounds described are currently
investigational and not approved for human use in the treatment of depression or suicidal crisis.